Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatology | 15 | 2024 | 918 | 4.170 |
Why?
|
Skin Diseases | 5 | 2024 | 1094 | 1.750 |
Why?
|
Exanthema | 3 | 2023 | 503 | 1.150 |
Why?
|
Teaching | 3 | 2018 | 1170 | 1.050 |
Why?
|
Sweet Syndrome | 1 | 2023 | 58 | 0.870 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5672 | 0.830 |
Why?
|
Primary Myelofibrosis | 1 | 2023 | 209 | 0.770 |
Why?
|
Faculty, Medical | 3 | 2018 | 1204 | 0.730 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.700 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2023 | 246 | 0.690 |
Why?
|
Pemphigoid, Bullous | 1 | 2021 | 112 | 0.680 |
Why?
|
Education, Medical, Undergraduate | 2 | 2018 | 1070 | 0.650 |
Why?
|
Drug Eruptions | 2 | 2021 | 335 | 0.620 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 3029 | 0.610 |
Why?
|
Internship and Residency | 4 | 2024 | 5882 | 0.600 |
Why?
|
Skin Diseases, Papulosquamous | 1 | 2017 | 17 | 0.590 |
Why?
|
Graft vs Host Reaction | 1 | 2017 | 102 | 0.590 |
Why?
|
Private Practice | 1 | 2018 | 153 | 0.580 |
Why?
|
Methotrexate | 2 | 2021 | 1719 | 0.570 |
Why?
|
Quality Improvement | 2 | 2024 | 3801 | 0.540 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2017 | 73 | 0.540 |
Why?
|
Education, Medical | 2 | 2018 | 1725 | 0.520 |
Why?
|
Career Choice | 2 | 2021 | 756 | 0.510 |
Why?
|
Calciphylaxis | 1 | 2017 | 130 | 0.500 |
Why?
|
Models, Educational | 1 | 2018 | 373 | 0.490 |
Why?
|
Carcinogens | 1 | 2017 | 452 | 0.490 |
Why?
|
Prisons | 1 | 2017 | 174 | 0.480 |
Why?
|
Bibliometrics | 1 | 2018 | 352 | 0.470 |
Why?
|
Salivary Gland Neoplasms | 1 | 2018 | 304 | 0.470 |
Why?
|
Arsenic | 1 | 2017 | 362 | 0.450 |
Why?
|
Internal Medicine | 1 | 2021 | 1051 | 0.450 |
Why?
|
Peer Group | 1 | 2018 | 692 | 0.420 |
Why?
|
Opiate Substitution Treatment | 1 | 2017 | 444 | 0.410 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.410 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2373 | 0.400 |
Why?
|
Biomedical Research | 2 | 2018 | 3429 | 0.400 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 625 | 0.400 |
Why?
|
Clinical Clerkship | 1 | 2018 | 564 | 0.400 |
Why?
|
Curriculum | 3 | 2024 | 3743 | 0.390 |
Why?
|
Learning | 2 | 2018 | 1740 | 0.380 |
Why?
|
Physicians, Women | 1 | 2017 | 509 | 0.380 |
Why?
|
Recurrence | 1 | 2023 | 8466 | 0.370 |
Why?
|
Immunosuppressive Agents | 2 | 2021 | 4176 | 0.370 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1505 | 0.350 |
Why?
|
Terminology as Topic | 1 | 2017 | 1530 | 0.350 |
Why?
|
Influenza Vaccines | 1 | 2017 | 768 | 0.340 |
Why?
|
Neurology | 1 | 2017 | 780 | 0.330 |
Why?
|
Psoriasis | 1 | 2017 | 950 | 0.320 |
Why?
|
Leadership | 1 | 2017 | 1385 | 0.300 |
Why?
|
Chronic Disease | 2 | 2024 | 9319 | 0.300 |
Why?
|
History, 18th Century | 2 | 2017 | 207 | 0.280 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1935 | 0.270 |
Why?
|
Psychiatry | 1 | 2017 | 1693 | 0.250 |
Why?
|
History, 19th Century | 2 | 2017 | 720 | 0.240 |
Why?
|
Vaccination | 1 | 2017 | 3384 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 3052 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3249 | 0.210 |
Why?
|
Humans | 31 | 2024 | 761572 | 0.200 |
Why?
|
Opioid-Related Disorders | 1 | 2017 | 2164 | 0.200 |
Why?
|
Communication | 1 | 2016 | 3873 | 0.200 |
Why?
|
Skin Diseases, Viral | 1 | 2021 | 26 | 0.190 |
Why?
|
Dementia | 1 | 2016 | 2689 | 0.190 |
Why?
|
Accreditation | 1 | 2024 | 473 | 0.190 |
Why?
|
Sclerosis | 1 | 2021 | 210 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5672 | 0.180 |
Why?
|
Purpura | 1 | 2021 | 117 | 0.180 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5336 | 0.170 |
Why?
|
Hyperpigmentation | 1 | 2021 | 117 | 0.170 |
Why?
|
Urban Health Services | 1 | 2021 | 177 | 0.170 |
Why?
|
Pressure Ulcer | 1 | 2021 | 157 | 0.170 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.160 |
Why?
|
History, 20th Century | 2 | 2017 | 2767 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 312 | 0.160 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5821 | 0.160 |
Why?
|
Hospitalization | 2 | 2021 | 10721 | 0.150 |
Why?
|
Paris | 1 | 2017 | 41 | 0.150 |
Why?
|
Hand Dermatoses | 1 | 2017 | 62 | 0.140 |
Why?
|
Edema | 1 | 2021 | 766 | 0.140 |
Why?
|
Scalp Dermatoses | 1 | 2017 | 44 | 0.140 |
Why?
|
Austria | 1 | 2017 | 207 | 0.140 |
Why?
|
Thiosulfates | 1 | 2017 | 53 | 0.140 |
Why?
|
Rural Health Services | 1 | 2021 | 384 | 0.140 |
Why?
|
Vaccines, Inactivated | 1 | 2017 | 179 | 0.140 |
Why?
|
Observation | 1 | 2018 | 310 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2759 | 0.130 |
Why?
|
England | 1 | 2017 | 526 | 0.130 |
Why?
|
Erythema | 1 | 2017 | 262 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12975 | 0.130 |
Why?
|
Clinical Competence | 2 | 2024 | 4793 | 0.130 |
Why?
|
Chelating Agents | 1 | 2017 | 387 | 0.130 |
Why?
|
Authorship | 1 | 2018 | 284 | 0.120 |
Why?
|
United States | 7 | 2024 | 72335 | 0.120 |
Why?
|
Geriatrics | 1 | 2019 | 388 | 0.120 |
Why?
|
Feedback | 1 | 2018 | 791 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13642 | 0.120 |
Why?
|
Problem-Based Learning | 1 | 2018 | 356 | 0.120 |
Why?
|
Time | 1 | 2016 | 546 | 0.120 |
Why?
|
Schools, Medical | 1 | 2021 | 879 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2115 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.100 |
Why?
|
Male | 10 | 2024 | 360842 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1302 | 0.090 |
Why?
|
Educational Status | 1 | 2018 | 2522 | 0.090 |
Why?
|
Fever | 1 | 2017 | 1618 | 0.090 |
Why?
|
Antioxidants | 1 | 2017 | 1668 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1881 | 0.080 |
Why?
|
Motivation | 1 | 2017 | 2006 | 0.070 |
Why?
|
Length of Stay | 1 | 2021 | 6426 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2018 | 1463 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.070 |
Why?
|
Middle Aged | 5 | 2024 | 220920 | 0.060 |
Why?
|
Female | 8 | 2024 | 392686 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5492 | 0.060 |
Why?
|
Patient Discharge | 1 | 2017 | 3443 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10553 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5440 | 0.050 |
Why?
|
Skin | 1 | 2017 | 4484 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2021 | 80646 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2021 | 64684 | 0.050 |
Why?
|
Adult | 4 | 2024 | 221203 | 0.050 |
Why?
|
Ointments | 1 | 2021 | 58 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11742 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26127 | 0.040 |
Why?
|
Aged | 5 | 2021 | 169310 | 0.040 |
Why?
|
Calcitriol | 1 | 2021 | 296 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 196 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5146 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2021 | 713 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10002 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2021 | 500 | 0.040 |
Why?
|
Physician Executives | 1 | 2019 | 134 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2021 | 313 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20571 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42230 | 0.030 |
Why?
|
Lower Extremity | 1 | 2021 | 1202 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1333 | 0.030 |
Why?
|
Child | 1 | 2017 | 80156 | 0.020 |
Why?
|
Animals | 1 | 2017 | 168467 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6770 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21355 | 0.010 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_